HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Okanoue Selected Research

LDL Cholesterol

6/2020Current and new pharmacotherapy options for non-alcoholic steatohepatitis.
11/2014Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.
1/2011Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.
12/2010Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Okanoue Research Topics

Disease

57Non-alcoholic Fatty Liver Disease
10/2023 - 01/2003
57Fibrosis (Cirrhosis)
06/2023 - 01/2003
34Hepatocellular Carcinoma (Hepatoma)
04/2023 - 02/2002
29Chronic Hepatitis C
03/2020 - 05/2002
28Neoplasms (Cancer)
01/2024 - 02/2002
21Liver Cirrhosis (Hepatic Cirrhosis)
10/2023 - 02/2002
19Infections
08/2020 - 08/2003
13Inflammation (Inflammations)
10/2023 - 10/2003
13Fatty Liver
01/2022 - 01/2003
13Chronic Hepatitis B
06/2018 - 08/2002
12Alcoholic Fatty Liver
02/2022 - 03/2009
12Insulin Resistance
01/2022 - 08/2003
7Body Weight (Weight, Body)
01/2023 - 03/2006
7Hepatitis
04/2022 - 02/2004
6Liver Diseases (Liver Disease)
01/2017 - 08/2002
6Hepatitis C
08/2014 - 09/2004
6Colitis
12/2008 - 03/2004
5Stomach Neoplasms (Stomach Cancer)
03/2021 - 11/2003
5Chronic Hepatitis (Chronic Active Hepatitis)
01/2010 - 08/2002
5Neoplasm Metastasis (Metastasis)
01/2007 - 01/2003
5Lymphoma (Lymphomas)
02/2006 - 09/2002
4Hemorrhage
04/2023 - 01/2004
4Iron Overload
01/2013 - 08/2003
4Hepatitis B
04/2010 - 07/2005
4Colonic Neoplasms (Colon Cancer)
01/2007 - 01/2003
4Reperfusion Injury
04/2006 - 01/2004
4Ischemia
03/2006 - 01/2004
4Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2005 - 03/2004
4Diarrhea
05/2005 - 03/2004
3Liver Neoplasms (Liver Cancer)
03/2021 - 05/2016
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2018
3Necrosis
02/2015 - 02/2004
3Fever (Fevers)
12/2006 - 03/2004
3Carcinoma (Carcinomatosis)
09/2005 - 07/2004

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2004
19InterferonsIBA
11/2015 - 05/2002
15Alanine Transaminase (SGPT)IBA
06/2023 - 08/2003
15Antiviral Agents (Antivirals)IBA
12/2020 - 02/2002
15Ribavirin (Virazole)FDA LinkGeneric
05/2015 - 07/2004
13Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2004
12Collagen Type IV (Type IV Collagen)IBA
06/2023 - 04/2010
12Transaminases (Aminotransferases)IBA
12/2021 - 08/2003
11DNA (Deoxyribonucleic Acid)IBA
10/2010 - 11/2003
10Messenger RNA (mRNA)IBA
03/2021 - 12/2002
10IronIBA
01/2013 - 06/2004
10Lamivudine (Epivir)FDA Link
09/2009 - 08/2002
8Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 01/2010
8EnzymesIBA
12/2020 - 09/2004
6selonsertibIBA
01/2023 - 11/2019
6Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 04/2009
6Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2011
6Hemoglobins (Hemoglobin)IBA
01/2021 - 05/2004
6AntigensIBA
05/2016 - 08/2002
6Reactive Oxygen Species (Oxygen Radicals)IBA
09/2010 - 07/2005
5Interleukin-6 (Interleukin 6)IBA
02/2015 - 08/2004
5Ferritins (Ferritin)IBA
01/2013 - 08/2003
5Peroxidase (Myeloperoxidase)IBA
08/2006 - 05/2004
5Thiobarbituric Acid Reactive SubstancesIBA
03/2006 - 05/2004
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2005 - 08/2002
5CytokinesIBA
10/2005 - 05/2004
4Amino AcidsFDA Link
10/2023 - 12/2010
4Aspartic Acid (Aspartate)FDA Link
06/2023 - 08/2002
4Triglycerides (Triacylglycerol)IBA
06/2023 - 01/2010
4gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
06/2023 - 01/2010
4Serum AlbuminIBA
04/2023 - 07/2005
4AlbuminsIBA
04/2023 - 08/2014
4nasIBA
01/2023 - 04/2010
4Immunoglobulin M (IgM)IBA
12/2022 - 12/2006
4Phospholipases (Phospholipase)IBA
12/2021 - 08/2015
4Vitamin EFDA LinkGeneric
12/2021 - 01/2006
4Insulin (Novolin)FDA Link
01/2021 - 01/2011
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2020 - 09/2010
4acarboxyprothrombin (PIVKA)IBA
08/2020 - 11/2004
4LDL CholesterolIBA
06/2020 - 12/2010
4RNA (Ribonucleic Acid)IBA
08/2014 - 09/2006
4Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2013 - 02/2004
4OligonucleotidesIBA
10/2010 - 02/2009
4ThioredoxinsIBA
04/2009 - 01/2003
4Anti-Bacterial Agents (Antibiotics)IBA
12/2006 - 03/2004
3CholesterolIBA
06/2023 - 01/2011
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2022 - 02/2002
3semaglutideIBA
01/2021 - 06/2020
3Glucagon-Like Peptide 1 (GLP 1)IBA
07/2020 - 03/2020
3Sodium-Glucose Transporter 2 InhibitorsIBA
07/2020 - 01/2018
3Sodium-Glucose Transport ProteinsIBA
07/2020 - 02/2020
3oxidized low density lipoproteinIBA
06/2020 - 01/2011
3Hepatitis B e AntigensIBA
09/2016 - 08/2006
3SimeprevirIBA
05/2015 - 05/2014
3Oxidants (Oxidizing Agents)IBA
02/2013 - 08/2010
3NucleosidesIBA
04/2010 - 06/2009
3entecavirFDA Link
01/2010 - 06/2009
3PPAR alphaIBA
04/2009 - 11/2004
3Rituximab (Mabthera)FDA Link
12/2008 - 03/2005
3Oxygen (Dioxygen)IBA
03/2006 - 10/2005
3Free RadicalsIBA
03/2006 - 10/2005
3NF-kappa B (NF-kB)IBA
02/2005 - 11/2003

Therapy/Procedure

54Therapeutics
01/2023 - 02/2002
12Drug Therapy (Chemotherapy)
03/2021 - 03/2004
5Liver Transplantation
04/2023 - 11/2019
5Aftercare (After-Treatment)
02/2021 - 10/2004